20240019419. MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF simplified abstract (CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION)
MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF
Organization Name
CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
Inventor(s)
MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240019419 titled 'MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF
Simplified Explanation
The abstract describes a patent application for a microfluidic bladder cancer mimic and its use in screening bladder cancer treatment substances. The bladder cancer mimic is produced using 3D printing, which allows for a more accurate representation of in vivo environments compared to conventional two-dimensional cell models. It is also simpler to produce than animal models. The lab-on-a-chip, which includes the bladder cancer mimic, can be used to develop anticancer therapeutic agents and patient-specific therapeutic agents using patient-derived bladder cancer cells.
- The patent application describes a microfluidic bladder cancer mimic produced through 3D printing.
- The mimic provides a more accurate representation of in vivo environments compared to conventional two-dimensional cell models.
- The mimic is simpler to produce than animal models.
- The lab-on-a-chip, including the bladder cancer mimic, can be used for screening bladder cancer treatment substances.
- The technology can aid in the development of anticancer therapeutic agents.
- The technology can be used to develop patient-specific therapeutic agents using patient-derived bladder cancer cells.
Potential Applications
- Screening bladder cancer treatment substances
- Development of anticancer therapeutic agents
- Development of patient-specific therapeutic agents
Problems Solved
- Lack of accurate representation of in vivo environments in conventional two-dimensional cell models
- Complexity and limitations of animal models for bladder cancer research
Benefits
- More accurate representation of bladder cancer in vivo environments
- Simplified production process compared to animal models
- Potential for personalized medicine using patient-derived bladder cancer cells
Original Abstract Submitted
a microfluidic bladder cancer mimic and the use thereof is provided. the bladder cancer mimic is produced through 3d printing, which may more accurately reflect in vivo environments than conventional two-dimensional cell models and may be more simply produced than animal models. a method of screening bladder cancer treatment substances using a lab-on-a-chip including the bladder cancer mimic that may be used for the development of anticancer therapeutic agents and may also be used to develop patient-specific therapeutic agents by using patient-derived bladder cancer cells.
